BDNF pretreatment of human embryonic-derived neural stem cells improves cell survival and functional recovery after transplantation in hypoxic-ischemic stroke

Cell Transplantation

Volumn 24, Issue 12, 2015, Pages 2449-2461

  Rosenblum, Sahar ^a,b   Smith, Tenille N ^a,b   Wang, Nancy ^a   Chua, Joshua Y ^a   Westbroek, Erick ^a   Wang, Kendrick ^a   Guzman, Raphael ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Brain derived neurotrophic factor (BDNF); Hypoxic ischemic (HI) stroke; Intravascular transplantation; Neural stem cells (NSCs); Pretreatment

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; COLONY STIMULATING FACTOR 1; NEURON SPECIFIC NUCLEAR PROTEIN; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 1; THROMBOSPONDIN 2; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; ALPHA CHEMOKINE; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN CORTEX; CELL FUNCTION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; HISTOLOGY; HUMAN; HUMAN CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SENSORIMOTOR FUNCTION; ANIMAL; BIOLOGICAL THERAPY; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; CELL MOTION; CONVALESCENCE; CYTOLOGY; EMBRYONIC STEM CELL; HEK293 CELL LINE; HYPOXIA-ISCHEMIA, BRAIN; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROCEDURES; SCID MOUSE; STROKE; TRANSPLANTATION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; CEREBRAL CORTEX; CHEMOKINES, CXC; EMBRYONIC STEM CELLS; HEK293 CELLS; HIPPOCAMPUS; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEURAL STEM CELLS; RECEPTORS, CHEMOKINE; RECOVERY OF FUNCTION; STROKE;

EID: 84949817832     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X679354     Document Type: Article

References (39)

1. Acheson, A.; Conover, J. C.; Fandl, J. P.; DeChiara, T. M.; Russell, M.; Thadani, A.; Squinto, S. P.; Yancopoulos, G. D.; Lindsay, R. M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374(6521): 450-453; 1995.
2. Ajmo, Jr., C. T.; Vernon, D. O.; Collier, L.; Pennypacker, K. R.; Cuevas, J. Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. Curr. Neurovasc. Res. 3(2):89-98; 2006.
3. Andres, R. H.; Choi, R.; Pendharkar, A. V.; Gaeta, X.; Wang, N.; Nathan, J. K.; Chua, J. Y.; Lee, S. W.; Palmer, T. D.; Steinberg, G. K.; Guzman, R. The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42(10):2923-2931; 2011.
4. Andres, R. H.; Horie, N.; Slikker, W.; Keren-Gill, H.; Zhan, K.; Sun, G.; Manley, N. C.; Pereira, M. P.; Sheikh, L. A.; McMillan, E. L.; Schaar, B. T.; Svendsen, C. N.; Bliss, T. M.; Steinberg, G. K. Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134(Pt 6):1777-1789; 2011.
5. Auriat, A. M.; Rosenblum, S.; Smith, T. N.; Guzman, R. Intravascular stem cell transplantation for stroke. Transl. Stroke Res. 2(3):250-265; 2011.
6. Bang, O. Y.; Lee, J. S.; Lee, P. H.; Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 57(6):874-882; 2005.
7. Barnabe-Heider, F.; Miller, F. D. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J. Neurosci. 23(12):5149-5160; 2003.
8. Butler, T. L.; Kassed, C. A.; Sanberg, P. R.; Willing, A. E.; Pennypacker, K. R. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res. 929(2):252-260; 2002.
9. Cai, W.; Guzman, R.; Hsu, A. R.; Wang, H.; Chen, K.; Sun, G.; Gera, A.; Choi, R.; Bliss, T.; He, L.; Li, Z. B.; Maag, A. L.; Hori, N.; Zhao, H.; Moseley, M.; Steinberg, G. K.; Chen, X. Positron emission tomography imaging of poststroke angiogenesis. Stroke 40(1):270-277; 2009.
10. Christopherson, K. S.; Ullian, E. M.; Stokes, C. C.; Mullowney, C. E.; Hell, J. W.; Agah, A.; Lawler, J.; Mosher, D. F.; Bornstein, P.; Barres, B. A. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120(3):421-433; 2005.
11. Chua, J. Y.; Pendharkar, A. V.; Wang, N.; Choi, R.; Andres, R. H.; Gaeta, X.; Zhang, J.; Moseley, M. E.; Guzman, R. Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J. Cereb. Blood Flow Metab. 31(5):1263-1271; 2011.
12. Francavilla, C.; Cattaneo, P.; Berezin, V.; Bock, E.; Ami, D.; de Marco, A.; Christofori, G.; Cavallaro, U. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J. Cell Biol. 187(7):1101-1116; 2009.
13. Guzman, R.; De Los Angeles, A.; Cheshier, S.; Choi, R.; Hoang, S.; Liauw, J.; Schaar, B.; Steinberg, G. Intracarotid injection of fluorescence activated cell-sorted CD49dpositive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 39(4):1300-1306; 2008.
14. Herz, J.; Reitmeir, R.; Hagen, S. I.; Reinboth, B. S.; Guo, Z.; Zechariah, A.; ElAli, A.; Doeppner, T. R.; Bacigaluppi, M.; Pluchino, S.; Kilic, U.; Kilic, E.; Hermann, D. M. Intracerebroventricularly delivered VEGF promotes contralesional corticorubral plasticity after focal cerebral ischemia via mechanisms involving anti-inflammatory actions. Neurobiol. Dis. 45(3):1077-1085; 2012.
15. Hill, W. D.; Hess, D. C.; Martin-Studdard, A.; Carothers, J. J.; Zheng, J.; Hale, D.; Maeda, M.; Fagan, S. C.; Carroll, J. E.; Conway, S. J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: Association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 63(1):84-96; 2004.
16. Horie, N.; Pereira, M. P.; Niizuma, K.; Sun, G.; Keren-Gill, H.; Encarnacion, A.; Shamloo, M.; Hamilton, S. A.; Jiang, K.; Huhn, S.; Palmer, T. D.; Bliss, T. M.; Steinberg, G. K. Transplanted stem cell-secreted VEGF effects post-stroke recovery, inflammation, and vascular repair. Stem Cells 29(2): 274-285; 2011.
17. Huang, E. J.; Reichardt, L. F. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 24: 677-736; 2001.
18. Huang, J.; Upadhyay, U. M.; Tamargo, R. J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66(3): 232-245; 2006.
19. Islam, O.; Loo, T. X.; Heese, K. Brain-derived neurotrophic factor (BDNF) has proliferative effects on neural stem cells through the truncated TRK-B receptor, MAP kinase, AKT, and STAT-3 signaling pathways. Curr. Neurovasc. Res. 6(1): 42-53; 2009.
20. Lee, H. J.; Kim, K. S.; Park, I. H.; Kim, S. U. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One 2(1):e156; 2007.
21. Lee, H. J.; Kim, M. K.; Kim, H. J.; Kim, S. U. Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS One 4(5):e5586; 2009.
22. Lee, H. J.; Lim, I. J.; Lee, M. C.; Kim, S. U. Human neural stem cells genetically modified to overexpress brain-derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J. Neurosci. Res. 88(15): 3282-3294; 2010.
23. Li, Y.; Chen, J.; Wang, L.; Lu, M.; Chopp, M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56(12):1666-1672; 2001.
24. Liauw, J.; Hoang, S.; Choi, M.; Eroglu, C.; Sun, G. H.; Percy, M.; Wildman-Tobriner, B.; Bliss, T.; Guzman, R. G.; Barres, B. A.; Steinberg, G. K. Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J. Cereb. Blood Flow Metab. 28(10):1722-1732; 2008.
25. Ma, H.; Yu, B.; Kong, L.; Zhang, Y.; Shi, Y. Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem. Res. 37(1):69-83; 2012.
26. Maness, P. F.; Schachner, M. Neural recognition molecules of the immunoglobulin superfamily: Signaling transducers of axon guidance and neuronal migration. Nat. Neurosci. 10(1): 19-26; 2007.
27. Markus, R.; Reutens, D. C.; Kazui, S.; Read, S.; Wright, P.; Pearce, D. C.; Tochon-Danguy, H. J.; Sachinidis, J. I.; Donnan, G. A. Hypoxic tissue in ischaemic stroke: Persistence and clinical consequences of spontaneous survival. Brain 127(Pt 6):1427-1436; 2004.
28. Metz, G. A.; Whishaw, I. Q. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: Anew task to evaluate fore- and hindlimb stepping, placing, and co-ordination. J. Neurosci. Methods 115(2):169-179; 2002.
29. Norazit, A.; Nguyen, M. N.; Dickson, C. G.; Tuxworth, G.; Goss, B.; Mackay-Sim, A.; Meedeniya, A. C. Vascular endothelial growth factor and platelet derived growth factor modulates the glial response to a cortical stab injury. Neuroscience 192:652-660; 2011.
30. Pendharkar, A. V.; Chua, J. Y.; Andres, R. H.; Wang, N.; Gaeta, X.; Wang, H.; De, A.; Choi, R.; Chen, S.; Rutt, B. K.; Gambhir, S. S.; Guzman, R. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 41(9):2064-2070; 2010.
31. Petridis, A. K.; El Maarouf, A. Brain-derived neurotrophic factor levels influence the balance of migration and differentiation of subventricular zone cells, but not guidance to the olfactory bulb. J. Clin. Neurosci. 18(2):265-270; 2011.
32. Piltonen, M.; Planken, A.; Leskela, O.; Myohanen, T. T.; Hanninen, A. L.; Auvinen, P.; Alitalo, K.; Andressoo, J. O.; Saarma, M.; Mannisto, P. T. Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons iin vitro iand iin vivoi. Neuroscience 192: 550-563; 2011.
33. Prag, S.; Lepekhin, E. A.; Kolkova, K.; Hartmann-Petersen, R.; Kawa, A.; Walmod, P. S.; Belman, V.; Gallagher, H. C.; Berezin, V.; Bock, E.; Pedersen, N. NCAM regulates cell motility. J. Cell Sci. 115(Pt 2):283-292; 2002.
34. Ray, P.; Tsien, R.; Gambhir, S. S. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res. 67(7): 3085-3093; 2007.
35. Rosenblum, S.; Wang, N.; Smith, T. N.; Pendharkar, A. V.; Chua, J. Y.; Birk, H.; Guzman, R. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke 43(6):1624-1631; 2012.
36. Stumm, R. K.; Rummel, J.; Junker, V.; Culmsee, C.; Pfeiffer, M.; Krieglstein, J.; Hollt, V.; Schulz, S. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: Isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22(14):5865-5878; 2002.
37. Yu, X.; Chen, D.; Zhang, Y.; Wu, X.; Huang, Z.; Zhou, H.; Zhang, Z. Overexpression of CXCR4 in mesenchymal stem cells promotes migration, neuroprotection and angiogenesis in a rat model of stroke. J. Neurol. Sci. 316(1-2): 141-149; 2012.
38. Yust-Katz, S.; Fisher-Shoval, Y.; Barhum, Y.; Ben-Zur, T.; Barzilay, R.; Lev, N.; Hod, M.; Melamed, E.; Offen, D. Placental mesenchymal stromal cells induced into neurotrophic factor-producing cells protect neuronal cells from hypoxia and oxidative stress. Cytotherapy 14(1): 45-55; 2012.
39. Zhang, Q.; Liu, G.; Wu, Y.; Sha, H.; Zhang, P.; Jia, J. BDNF promotes EGF-induced proliferation and migration of human fetal neural stem/progenitor cells via the PI3K/Akt pathway. Molecules 16(12):10146-10156; 2011.